Rankings
▼
Calendar
VCEL Q2 2019 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$26M
+37.6% YoY
Gross Profit
$17M
65.5% margin
Operating Income
-$20M
-77.2% margin
Net Income
-$20M
-75.7% margin
EPS (Diluted)
$-0.45
QoQ Revenue Growth
+19.9%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$19M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$126M
Total Liabilities
$37M
Stockholders' Equity
$89M
Cash & Equivalents
$14M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$26M
$19M
+37.6%
Gross Profit
$17M
$11M
+51.8%
Operating Income
-$20M
-$4M
-375.7%
Net Income
-$20M
-$5M
-325.5%
Revenue Segments
Product
$26M
100%
← FY 2019
All Quarters
Q3 2019 →